Thomson Reuters, a US-based provider of information for businesses and professionals, has announced the availability of the Pharma Matters quarterly reports covering the period October-December 2007. The report series, launched two years ago, covers all aspects of the pharmaceutical pipeline. It is projected to leverage strategic intelligence and competitive analysis from Thomson Pharma, Newport Horizon Premium and the Thomson Messaging Mapping System.
The report Who is Making the Biggest Splash? is an expert review of the organisations that are helping to shape professional opinions on drugs and therapies, using the insights of the Thomson Message Mapping System. In this quarterly review of the scientific literature on drugs and therapies, Thomson Reuters assesses the quantity and quality of the materials published by pharmaceutical companies, research institutions and other non-commercial bodies.
The Ones to Watch, a Thomson Reuters quarterly review of the latest phase changes in the pharmaceutical pipeline, is based on the strategic data and analysis from Thomson Pharma, a pharmaceutical competitive intelligence solution. Detailed analysis, as well as information on drugs entering clinical Phases I, II and III, are available in the full report at http://scientific.thomson.com/thomsonpharma/media/pdfs/tpqr/tp_qr_oct-dec_07.pdf.
Introduced in mid-2007, the Movers and Shakers report is the latest in the Pharma Matters series. It covers the US generics industry using data and analysis from Newport Horizon Premium, a product targeting the global business development system.
Interested parties can sign up for Thomson Reuters' series of reviews covering all aspects of the pharmaceutical marketplace at http://scientific.thomson.com/pharma/forms/matters/.
